Showing results (101-110 of 150) with videos related to
Sort By:
Pageof 15
Circulation|July 1, 1994
Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II InvestigatorsF V Aguirre, R P McMahon, H Mueller, et al.Chemosphere|July 12, 2017
Are the TiO2 NPs a "Trojan horse" for personal care products (PCPs) in the clam Ruditapes philippinarum?M Sendra, M G Pintado-Herrera, G V Aguirre-Martínez, et al.Journal of the American College of Cardiology|January 13, 1998
Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic ComplicationsM M Khan, S G Ellis, F V Aguirre, et al.Journal of the American College of Cardiology|August 1, 1993
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot StudyN S Kleiman, E M Ohman, R M Califf, et al.Catheterization and Cardiovascular Diagnosis|April 1, 1993
Superior accuracy of anatomic positioning with echocardiographic- over fluoroscopic-guided endomyocardial biopsyC A Bell, M J Kern, F V Aguirre, et al.Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)|September 27, 2013
[Cultural adaptation and Argentine validation of the Northwick Park Neck Pain Questionnaire in the hospitals of the Autonomous City of Buenos Aires]Mariana V Aguirre, Matias G Rodríguez, Martín Clarett, et al.Journal of the American College of Cardiology|August 26, 1998
Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment EvaluationN R Every, C P Cannon, C Granger, et al.Journal of the American College of Cardiology|July 1, 1997
Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic ComplicationsA M Lincoff, R M Califf, K M Anderson, et al.American Heart Journal|December 6, 2011
The kinetics of integrilin limited by obesity: a multicenter randomized pharmacokinetic and pharmacodynamic clinical trialJohn P Vavalle, Susanna R Stevens, Nancy Hassinger, et al.Circulation|June 15, 1995
Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC InvestigatorsF V Aguirre, E J Topol, J J Ferguson, et al.Pageof 15